• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制松弛素自分泌信号可赋予卵巢癌治疗上的脆弱性。

Inhibition of relaxin autocrine signaling confers therapeutic vulnerability in ovarian cancer.

机构信息

Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, Ontario, Canada.

Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.

出版信息

J Clin Invest. 2021 Apr 1;131(7). doi: 10.1172/JCI142677.

DOI:10.1172/JCI142677
PMID:33561012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8011889/
Abstract

Ovarian cancer (OC) is the most deadly gynecological malignancy, with unmet clinical need for new therapeutic approaches. The relaxin peptide is a pleiotropic hormone with reproductive functions in the ovary. Relaxin induces cell growth in several types of cancer, but the role of relaxin in OC is poorly understood. Here, using cell lines and xenograft models, we demonstrate that relaxin and its associated GPCR RXFP1 form an autocrine signaling loop essential for OC in vivo tumorigenesis, cell proliferation, and viability. We determined that relaxin signaling activates expression of prooncogenic pathways, including RHO, MAPK, Wnt, and Notch. We found that relaxin is detectable in patient-derived OC tumors, ascites, and serum. Further, inflammatory cytokines IL-6 and TNF-α activated transcription of relaxin via recruitment of STAT3 and NF-κB to the proximal promoter, initiating an autocrine feedback loop that potentiated expression. Inhibition of RXFP1 or relaxin increased cisplatin sensitivity of OC cell lines and abrogated in vivo tumor formation. Finally, we demonstrate that a relaxin-neutralizing antibody reduced OC cell viability and sensitized cells to cisplatin. Collectively, these data identify the relaxin/RXFP1 autocrine loop as a therapeutic vulnerability in OC.

摘要

卵巢癌 (OC) 是最致命的妇科恶性肿瘤,临床上迫切需要新的治疗方法。松弛肽是一种具有生殖功能的多功能激素,在卵巢中。松弛肽可诱导多种类型的癌症细胞生长,但松弛肽在 OC 中的作用知之甚少。在这里,我们使用细胞系和异种移植模型证明,松弛肽及其相关 GPCR RXFP1 形成了一种自分泌信号环路,对于体内 OC 肿瘤发生、细胞增殖和活力是必不可少的。我们确定松弛肽信号激活了致癌途径的表达,包括 RHO、MAPK、Wnt 和 Notch。我们发现松弛肽可在患者来源的 OC 肿瘤、腹水和血清中检测到。此外,炎性细胞因子 IL-6 和 TNF-α 通过募集 STAT3 和 NF-κB 到近端启动子来激活松弛肽的转录,启动自分泌反馈环,增强表达。抑制 RXFP1 或松弛肽增加了 OC 细胞系对顺铂的敏感性,并消除了体内肿瘤的形成。最后,我们证明松弛肽中和抗体降低了 OC 细胞的活力,并使细胞对顺铂敏感。总之,这些数据表明松弛肽/RXFP1 自分泌环是 OC 的治疗弱点。

相似文献

1
Inhibition of relaxin autocrine signaling confers therapeutic vulnerability in ovarian cancer.抑制松弛素自分泌信号可赋予卵巢癌治疗上的脆弱性。
J Clin Invest. 2021 Apr 1;131(7). doi: 10.1172/JCI142677.
2
The consequences of manipulating relaxin family peptide receptor 1 (RXFP1) level in ovarian cancer cells.调控卵巢癌细胞中松弛素家族肽受体 1(RXFP1)水平的后果。
Reprod Biol. 2024 Jun;24(2):100864. doi: 10.1016/j.repbio.2024.100864. Epub 2024 Apr 19.
3
VPS33B interacts with NESG1 to suppress cell growth and cisplatin chemoresistance in ovarian cancer.VPS33B 通过与 NESG1 相互作用抑制卵巢癌细胞生长和顺铂化疗耐药性。
Cancer Sci. 2021 May;112(5):1785-1797. doi: 10.1111/cas.14864. Epub 2021 Mar 31.
4
Relaxin activates peroxisome proliferator-activated receptor γ (PPARγ) through a pathway involving PPARγ coactivator 1α (PGC1α).松弛素通过一条涉及过氧化物酶体增殖物激活受体γ辅助激活因子1α(PGC1α)的途径激活过氧化物酶体增殖物激活受体γ(PPARγ)。
J Biol Chem. 2015 Jan 9;290(2):950-9. doi: 10.1074/jbc.M114.589325. Epub 2014 Nov 11.
5
The chemically synthesized human relaxin-2 analog, B-R13/17K H2, is an RXFP1 antagonist.化学合成的人松弛素-2 类似物 B-R13/17K H2 是 RXFP1 拮抗剂。
Amino Acids. 2010 Jul;39(2):409-16. doi: 10.1007/s00726-009-0454-1. Epub 2009 Dec 31.
6
Emerging roles for the relaxin/RXFP1 system in cancer therapy.松弛素/ RXFP1 系统在癌症治疗中的新作用。
Mol Cell Endocrinol. 2019 May 1;487:85-93. doi: 10.1016/j.mce.2019.02.001. Epub 2019 Feb 11.
7
P-MAPA immunotherapy potentiates the effect of cisplatin on serous ovarian carcinoma through targeting TLR4 signaling.P-MAPA 免疫疗法通过靶向 TLR4 信号通路增强顺铂对浆液性卵巢癌的疗效。
J Ovarian Res. 2018 Jan 17;11(1):8. doi: 10.1186/s13048-018-0380-5.
8
Reversal of cisplatin resistance by microRNA-139-5p-independent RNF2 downregulation and MAPK inhibition in ovarian cancer.microRNA-139-5p 非依赖性 RNF2 下调和 MAPK 抑制逆转卵巢癌顺铂耐药。
Am J Physiol Cell Physiol. 2018 Aug 1;315(2):C225-C235. doi: 10.1152/ajpcell.00283.2017. Epub 2018 May 2.
9
Interleukin 6 promotes endometrial cancer growth through an autocrine feedback loop involving ERK-NF-κB signaling pathway.白细胞介素 6 通过涉及 ERK-NF-κB 信号通路的自分泌反馈环促进子宫内膜癌生长。
Biochem Biophys Res Commun. 2014 Mar 28;446(1):167-72. doi: 10.1016/j.bbrc.2014.02.080. Epub 2014 Feb 25.
10
Transmembrane protein 88 (TMEM88) promoter hypomethylation is associated with platinum resistance in ovarian cancer.跨膜蛋白88(TMEM88)启动子低甲基化与卵巢癌铂耐药相关。
Gynecol Oncol. 2016 Sep;142(3):539-47. doi: 10.1016/j.ygyno.2016.06.017. Epub 2016 Jun 30.

引用本文的文献

1
Impact of tumor necrosis factor-alpha and lysophosphatidic acid on the behavior of ovarian cancer cells in a three-dimensional collagen hydrogel.肿瘤坏死因子-α和溶血磷脂酸对三维胶原水凝胶中卵巢癌细胞行为的影响
J Obstet Gynaecol Res. 2025 Aug;51(8):e70026. doi: 10.1111/jog.70026.
2
Exploiting Cancer Dormancy Signaling Mechanisms in Epithelial Ovarian Cancer Through Spheroid and Organoid Analysis.通过球体和类器官分析探索上皮性卵巢癌中的癌症休眠信号机制
Cells. 2025 Jan 17;14(2):133. doi: 10.3390/cells14020133.
3
Relaxin-2 is a novel biomarker for differentiated thyroid carcinoma in humans.松弛素-2 是人类分化型甲状腺癌的一种新型生物标志物。
Biochem Pharmacol. 2024 Jul;225:116323. doi: 10.1016/j.bcp.2024.116323. Epub 2024 May 28.
4
The diverse influences of relaxin-like peptide family on tumor progression: Potential opportunities and emerging challenges.松弛素样肽家族对肿瘤进展的多种影响:潜在机遇与新挑战
Heliyon. 2024 Jan 10;10(2):e24463. doi: 10.1016/j.heliyon.2024.e24463. eCollection 2024 Jan 30.
5
Development of Novel High-Affinity Antagonists for the Relaxin Family Peptide Receptor 1.新型松弛素家族肽受体1高亲和力拮抗剂的研发
ACS Pharmacol Transl Sci. 2023 May 3;6(5):842-853. doi: 10.1021/acsptsci.3c00053. eCollection 2023 May 12.
6
The dual and multifaceted role of relaxin-2 in cancer.松弛素-2 在癌症中的双重和多方面作用。
Clin Transl Oncol. 2023 Oct;25(10):2763-2771. doi: 10.1007/s12094-023-03146-0. Epub 2023 Mar 22.
7
Histone methyltransferase SETD1A interacts with notch and promotes notch transactivation to augment ovarian cancer development.组蛋白甲基转移酶 SETD1A 与 notch 相互作用,并促进 notch 转录激活,从而增强卵巢癌的发展。
BMC Cancer. 2023 Jan 27;23(1):96. doi: 10.1186/s12885-023-10573-3.
8
Evaluation of pharmacological activities and active components in by instrumental and virtual analyses.通过仪器分析和虚拟分析评估[具体内容]中的药理活性和活性成分。 需注意,原文中“in by”表述有误,推测完整表述可能是“in [具体事物] by...” ,这里按正确理解进行了翻译。
Front Nutr. 2022 Dec 7;9:1083581. doi: 10.3389/fnut.2022.1083581. eCollection 2022.
9
The Cell Surface Heparan Sulfate Proteoglycan Syndecan-3 Promotes Ovarian Cancer Pathogenesis.细胞表面硫酸乙酰肝素蛋白聚糖连接蛋白-3 促进卵巢癌发病机制。
Int J Mol Sci. 2022 May 21;23(10):5793. doi: 10.3390/ijms23105793.
10
Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines.利用G蛋白偶联受体作为分子信标,用纳米药物靶向卵巢癌。
Cancers (Basel). 2022 May 10;14(10):2362. doi: 10.3390/cancers14102362.

本文引用的文献

1
Next-generation characterization of the Cancer Cell Line Encyclopedia.下一代癌症细胞系百科全书的特征描述。
Nature. 2019 May;569(7757):503-508. doi: 10.1038/s41586-019-1186-3. Epub 2019 May 8.
2
Emerging roles for the relaxin/RXFP1 system in cancer therapy.松弛素/ RXFP1 系统在癌症治疗中的新作用。
Mol Cell Endocrinol. 2019 May 1;487:85-93. doi: 10.1016/j.mce.2019.02.001. Epub 2019 Feb 11.
3
Follicle-Stimulating Hormone Is an Autocrine Regulator of the Ovarian Cancer Metastatic Niche Through Notch Signaling.促卵泡激素是通过Notch信号通路对卵巢癌转移微环境起自分泌调节作用的因子。
J Endocr Soc. 2018 Dec 12;3(2):340-357. doi: 10.1210/js.2018-00272. eCollection 2019 Feb 1.
4
IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis.白细胞介素-6与卵巢癌:促进转移的炎性细胞因子
Cancer Manag Res. 2018 Dec 5;10:6685-6693. doi: 10.2147/CMAR.S179189. eCollection 2018.
5
Lysophospholipid Signaling in the Epithelial Ovarian Cancer Tumor Microenvironment.上皮性卵巢癌肿瘤微环境中的溶血磷脂信号传导
Cancers (Basel). 2018 Jul 9;10(7):227. doi: 10.3390/cancers10070227.
6
Levels Serve as "Early Signature" Genes in the Development of High-Grade Serous Carcinoma from the Fallopian Tube.水平基因可作为输卵管高级别浆液性癌发生的“早期特征性”基因。
Cancer Res. 2018 Apr 1;78(7):1739-1750. doi: 10.1158/0008-5472.CAN-17-1671. Epub 2018 Jan 16.
7
Notch and its oncogenic activity in human malignancies.Notch及其在人类恶性肿瘤中的致癌活性。
Eur Surg. 2017;49(5):199-209. doi: 10.1007/s10353-017-0491-z. Epub 2017 Sep 18.
8
Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells.拷贝数效应的计算校正提高了CRISPR-Cas9在癌细胞中必需性筛选的特异性。
Nat Genet. 2017 Dec;49(12):1779-1784. doi: 10.1038/ng.3984. Epub 2017 Oct 30.
9
Serum relaxin as a diagnostic and prognostic marker in patients with epithelial ovarian cancer.血清松弛素作为上皮性卵巢癌的诊断和预后标志物。
Cancer Biomark. 2017 Dec 12;21(1):81-87. doi: 10.3233/CBM-170278.
10
Tumor-Host Cell Interactions in Ovarian Cancer: Pathways to Therapy Failure.卵巢癌中的肿瘤-宿主细胞相互作用:治疗失败的途径
Trends Cancer. 2017 Feb;3(2):137-148. doi: 10.1016/j.trecan.2016.12.005. Epub 2017 Jan 18.